Evidence map›Paper›PMID 20980464›Full record

ArticleSexually transmitted infections2011

Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy.

Susan M Graham, Linnet Masese, Ruth Gitau, Barbra A Richardson, Kishor Mandaliya, Norbert Peshu, Walter Jaoko, Jeckoniah Ndinya-Achola, Julie Overbaugh, R Scott McClelland

Abstract read
In one paragraph

Article in Sexually transmitted infections, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Susan M GrahamUniversity of Washington, Box 359909, 325 Ninth Avenue, Seattle, WA 98104-2499, USA. grahamsm@u.washington.edu
Linnet Masese
Ruth Gitau
Barbra A Richardson
Kishor Mandaliya
Norbert Peshu
Walter Jaoko
Jeckoniah Ndinya-Achola
Julie Overbaugh
R Scott McClelland

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Judith Tsui · 1988 to 2026
$104.9M
Antiretroviral Therapy and HIV-1 Infectivity in WomenR01AI058698 · NIAID · UNIVERSITY OF WASHINGTON · PI MCCLELLAND, RAYMOND SCOTT · 2005 to 2010
$2.8M
Genital HIV-1 Shedding among Women Starting Second-Line Antiretroviral TherapyK23AI069990 · NIAID · UNIVERSITY OF WASHINGTON · PI GRAHAM, SUSAN MARIE · 2006 to 2010
$633k
NIAID NIH HHS K23 AI069990NIAID NIH HHS K23 AI69990NIAID NIH HHS P30 AI027757NIAID NIH HHS P30-AI027757NIAID NIH HHS R01 AI058698
6 · The paper itself

Abstract

objectivesGenital ulcer disease (GUD) is associated with increased HIV-1-RNA shedding in antiretroviral therapy (ART)-naive women. The effect of GUD on HIV-1 shedding among ART-treated women is not known. The objective of this study was to test the hypothesis that genital ulcerations increase genital HIV-1-RNA shedding in women receiving ART.

methodsEligible women initiated ART and attended monthly visits with inspection for genital lesions and collection of genital swabs. GUD cases diagnosed after 2 months or more on ART were included for analysis and served as their own controls. HIV-1 RNA was quantitated in specimens collected before, during and after GUD for all cases. The lower limit of quantitation was 100 HIV-1-RNA copies/swab. Using the pre-GUD visit as the reference, the detection of genital HIV-1 RNA before versus during and after GUD episodes was compared.

results36 women had GUD episodes after ART initiation. HIV-1 RNA was detected before, during and after GUD in cervical secretions from four (11%), one (3%) and six (17%) women, respectively, and in vaginal secretions from three (8%), four (11%) and four (11%) women, respectively. After adjustment for time on ART, there was no difference in the detection of cervical HIV-1 RNA before versus during GUD (adjusted OR 0.22, 95% CI 0.04 to 1.23). Likewise, GUD did not increase HIV-1 detection in vaginal secretions (adjusted OR 1.32, 95% CI 0.29 to 5.92).

conclusionsGUD did not significantly increase cervical or vaginal HIV-1 shedding. The results suggest that ART maintains its effectiveness for genital HIV-1 suppression despite GUD episodes.

Indexed as

HIV-1Virus SheddingAdultAnti-HIV AgentsCervix UteriFemaleHIV InfectionsHumansMucusProspective StudiesRNA, ViralUlcerUterine Cervical DiseasesVaginaVaginal DiseasesAnti-HIV AgentsRNA, Viral

Identifiers

PMID20980464
PMCPMC3081651

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.